Monthly Archives: December 2012

2012 Biotech Gift Guide

xmas-presents

Welcome to this year’s BIOtechNOW Gift Guide, our most loved biotech gift ideas from 2012 and beyond. Here you’ll find gifts that track your genetic history, interesting biotech books, and art! So whether you’re looking for a last-minute gift idea or a way to blow part of that holiday bonus consider this your guide to yuletide biotech bliss! Add your suggestions in the comments! 23andMe 23andMe is a DNA analysis service providing information and tools Read More >

Corporate  |  Leave a comment  |  Email This Post
Tags: , , , ,

Harder, Better, Faster, Stronger: Takeaways from Partnering For Cures 2012

Drug Manufacturing

The chorus to Kanye West’s 2007 chart-topper Stronger can teach us volumes about speeding drug development. Harder:  Drug development is challenging.  It takes over 10 years and more than $1 billon to bring a therapy through the product pipeline, from the research lab to clinical trials to FDA approval to prescription to patients suffering from the disease. The FDA approved over 30 innovative drugs last year, including more than 10 new treatments for cancer—a good Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

FDASIA: A Step Forward for Patients

fdasia-panel

Earlier this year, Congress passed and President Obama signed the FDA Safety and Innovation Act (FDASIA) which included a re-authorization of the Prescription Drug User Fee Act (PDUFA). PDUFA provides essential funding to the FDA by authorizing the agency to charge user fees to companies seeking to have products reviewed. Originally enacted in 1992, it must be reauthorized every 5 years. Sara Radcliffe, executive vice president of health at BIO, moderated a panel of experts and advocates Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,

Delivering on the Promise of Personalized Medicine

185x185_ad_btn_home

As sequencing moves out of the lab and into the clinic, a host of players must get involved to make our collective promises of personalized medicine a reality. CEOs, entrepreneurs, researchers, clinicians, regulators and payers need to work together to take on the next challenges in the implementation of personalized medicine. Some of those challenges include: Cost vs. Benefit: How do we define and benefit from transformational technologies? Form vs. Function: What about the less Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Fast Food vs. Fuel

biofuels-btn

The National Council of Chain Restaurants, a member of the Smarter Fuel Future coalition that includes national petroleum refining and meat producer trade groups, recently launched a new front in the effort to dismantle the Renewable Fuel Standard. The group released a study compiled by PricewaterhouseCoopers, an editorial in the Wall Street Journal and followed up with a round of lobbying on Capitol Hill. The claims made in the NCCR-funded report are at best unrealistic. Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , , ,